12:46 PM EST, 11/14/2024 (MT Newswires) -- NRX Pharmaceuticals ( NRXP ) on Thursday filed a preliminary prospectus for the sale of up to 3,304,374 of the company's common stock from time to time by some of its shareholders.

The shares are issuable if the holders of the company's 6% senior secured note convert the debt into equity and exercise their warrants for stock in full.

The company identified the selling shareholders as Anson Investments Master Fund and Anson East Master Fund.

The company said it would not receive any proceeds from the resale of its shares.

Shares of NRX Pharmaceuticals ( NRXP ) were down 6.4% in recent trading.

Price: 1.17, Change: -0.08, Percent Change: -6.40